SUBSCRIBE
SUBSCRIBE
News   Policy

Novartis Pharma K.K. Files Applicaion Seeking Additional Indication For Glivec In Japan

December 27, 2005 | 
1 min read
Tokyo (JCN) Dec 26, 2005 - Novartis Pharma announced on December 26 that it has filed an application for an additional indication of Glivec (imatinib), its proprietary molecular-targeted agent, with the Ministry of Health, Labor and Welfare.
Regulatory Asia
MORE ON THIS TOPIC
CDC
Republicans Ratchet Up Pressure as Monarez Levels Damning Allegations Against Kennedy
September 17, 2025
 · 
4 min read
 · 
Heather McKenzie
Businessman tied up with red tape. concept of struggle, limitation and trap or challenge
FDA
FDA’s Ad Crackdown Targets Novo, Lilly’s Oprah Special on GLP-1s
September 17, 2025
 · 
3 min read
 · 
Annalee Armstrong
Podcast
China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More
September 17, 2025
 · 
2 min read
 · 
Heather McKenzie
man pulling each of the opposite ends of a rope in black and white, on a blue background with some blank space on top
Obesity
Novo, Lilly Jostle For Market Lead in Obesity With New Regulatory Efforts
September 16, 2025
 · 
2 min read
 · 
Tristan Manalac